Covered recipient · General Payments record
BRIAN KYLE MACY
Allopathic & Osteopathic Physicians Family Medicine Sports Medicine
General Payments · PY2018–2024
$1,411.12
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.44 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $225.73 | 18 |
| Merck Sharp & Dohme Corporation | $26.85 | 2 |
| Amgen Inc. | $18.77 | 1 |
| Astellas Pharma US Inc | $18.07 | 1 |
| Seqirus USA Inc | $17.82 | 1 |
| Novo Nordisk AS | $14.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.06 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921030 | CMS |
| ABBVIE INC. | $25.64 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921032 | CMS |
| ABBVIE INC. | $7.67 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921034 | CMS |
| ABBVIE INC. | $10.60 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921036 | CMS |
| ABBVIE INC. | $7.80 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921038 | CMS |
| ABBVIE INC. | $4.76 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921040 | CMS |
| ABBVIE INC. | $3.02 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921042 | CMS |
| ABBVIE INC. | $19.81 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921044 | CMS |
| ABBVIE INC. | $8.81 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921046 | CMS |
| ABBVIE INC. | $9.64 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921048 | CMS |
| ABBVIE INC. | $18.93 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921050 | CMS |
| ABBVIE INC. | $16.61 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921052 | CMS |
| ABBVIE INC. | $16.83 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921054 | CMS |
| ABBVIE INC. | $19.03 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921056 | CMS |
| ABBVIE INC. | $3.71 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921058 | CMS |
| ABBVIE INC. | $3.71 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921060 | CMS |
| ABBVIE INC. | $13.03 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921062 | CMS |
| ABBVIE INC. | $33.07 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104921064 | CMS |
| Amgen Inc. | $18.77 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117316210 | CMS |
| Astellas Pharma US Inc | $18.07 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139415283 | CMS |
| Merck Sharp & Dohme LLC | $13.49 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141887047 | CMS |
| Merck Sharp & Dohme LLC | $13.36 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141753654 | CMS |
| Novo Nordisk Inc | $14.20 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097575289 | CMS |
| Seqirus USA Inc | $17.82 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125632698 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.